CIS Pharma initiates a proof of concept program for its novel polymer-drug carriers tailored to radioisotopes

Bubendorf, Switzerland, Wednesday, September 5, 2019 - CIS Pharma has signed a research agreement with the Paul Scherer Institute, Switzerland. The program comprises an invitro and invivo program for the [...]

CIS Pharma summer event at the Rhine Falls

Schaffhausen, Switzerland, Friday, July 19,  2019 - During our Summer Event we take a boat ride along the banks of the Rhine Falls in Schaffhausen. The spectacular falls offers a [...]

CIS Pharma initiates a new R&D program in the field of PEEK implants

Bubendorf, Switzerland, Thursday, April 25, 2019 - In a new research program the surface of PEEK medical implants will modified to enhance osteointegration and soft-tissue compatibility. The modification is targeting the [...]

CIS Pharma Christmas event in Bern

Bern, Switzerland, Friday, December 7, 2018 - For the end of year event, the team of CIS Pharma sets out to Bern, the capital of Switzerland. Our city guide Domenico [...]

CIS Pharma starts collaboration with the Paul Scherer Institute on antibody-radionuclide conjugates

Bubendorf, Switzerland, Thursday, November 22, 2018 - CIS Pharma has identified the group of Prof. Schibli and Dr. Behe from the Paul Scherer Institute, ETH,  as potential partners for its [...]

CIS Pharma summer event in Basel

Basel, Switzerland, Tuesday, September 11, 2018 - During our Summer Event we dive into the multifaceted side of Basel, Kleinbasel, at the northern banks of the river Rhine. Our trip [...]

Approval received for innovative vial adaptor, available now for market introduction

Bubendorf, Switzerland, Friday, August 30, 2018 – CIS Pharma announces the approval of a vial adaptor specific for the preparation and injection of intracameral cefuroxime. Consequently, the adaptor was produced [...]

CIS Pharma initiates a new R&D program on antibody-radionuclide conjugates

Bubendorf, Switzerland, Tuesday, July 10, 2018 - Over the course of the past months, CIS Pharma has developed concepts and strategies to conjugate  radioisotopes onto its polymer-drug carriers. First syntheses [...]

Intracameral cefuroxime launched in Europe

Bubendorf, Switzerland, Monday, February 26, 2018  - CIS Pharma’s licensee has launched intracameral cefuroxime across Europe. Among others, cataract clinics in France, Germany, Spain, Italy and Netherlands will be supplied [...]

CIS Pharma has reached the first milestone in its SNI funded project

Bubendorf, Switzerland, Thursday, December 21, 2017 - CIS Pharma’s bio-membrane project has reached the first milestone. The polymer chemistry experts developed the a first prototype compatible with the 3D printing [...]